Transplant Treatment Path: Optimizing Patient-Centered Care for ASCT in Multiple Myeloma
Transplant Treatment Path: Optimizing Patient-Centered Care for ASCT in Multiple Myeloma is an ACCC educational initiative aimed at improving provider communication to optimize the treatment of multiple myeloma patients in the community cancer center pre- and post-autologous stem cell transplant (ASCT). This project will explore the reasons for, and develop suggestions to correct, discrepancies in the treatment journey for patients with multiple myeloma who receive ASCT as part of their therapy. Four ACCC-member programs with transplants centers will be participating in the project:
- Emory University Bone Marrow and Stem Cell Transplant, Winship Cancer Institute
- Seattle Cancer Care Alliance
- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at The Ohio State University
- Texas Transplant Institute, Methodist Healthcare System
ACCC is conducting a needs assessment survey to measure ACCC members needs in treating patients with multiple myeloma and to better understand the patient treatment journey pre– and post–ASCT.
Take our survey here.